Skip to main content
. 2022 Feb 24;12(3):579. doi: 10.3390/diagnostics12030579

Table 2.

Cases of IHC and TP53 mutation type mismatching (order by AA sequence).

Type AA Change Domain Mutation
Type
IHC
Staining
Tumor
%
VAF
endometrioid V73W fs*50 TD FSD WT 30 10.3
clear cell G105R DBD MM WT 80 49.88
HGSCa S183* DBD NM “All” 70 42.67
HGSCa F212_H214del DBD IFD “All” 70 13.62
endometrioid S261_G262dup DBD IFI WT 40 16.71
HGSCa G262del DBD IFD “All” 80 32.92
HGSCa R273H DBD MM “None” 90 0.75
HGSCa L289F fs*57 DBD FSI Cyto 70 23.66
HGSCa P301Q fs*44 NLS FSD WT 60 27.28
HGSCa P301Q fs*44 NLS FSD “All” 90 82.71
HGSCa R306* NLS NM Cyto 80 0.86
HGSCa R306* NLS NM WT + Cyto 80 0.60
HGSCa R342E fs*3 OD FSI “All” 30 36.69
HGSCa R342* OD NM “All” + Cyto 90 37.4
HGSCa R342* OD NM “All” 50 7.08
HGSCa R342* OD NM “All” 60 44.4
HGSCa E343* OD NM WT 90 0.31
HGSCa E346* OD NM “All” 90 0.35